International Multicentre Prevalence Study on Sepsis
IMPRESS
Surviving Sepsis Campaign. International Multicentre Prevalence Study on Sepsis.
1 other identifier
observational
1,000
1 country
1
Brief Summary
To mark 10 years of the Surviving Sepsis Campaign (SSC), and timed to coincide with World Sepsis Day, on September 13, 2013, the SSC, ESICM and SCCM will be conducting an international point prevalence study of severe sepsis and septic shock. The goal of this project is to determine the world wide burden of severe sepsis and define current practices of sepsis care internationally. The study is a simple data collection exercise for patients presenting with either severe sepsis or septic shock on World Sepsis Day.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2013
CompletedFirst Posted
Study publicly available on registry
September 17, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedAugust 20, 2014
August 1, 2014
Same day
September 12, 2013
August 19, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
28-Day Mortality
one week
Secondary Outcomes (1)
Organ Failure
one week
Other Outcomes (1)
Length of Stay in the Hospital
one week
Eligibility Criteria
patients presenting with either severe sepsis or septic shock
You may qualify if:
- To be eligible patients must have all of the following:
- Must be admitted or transferred to either the ED or an Intensive Care Unit.
- Have a high clinical suspicion of an infection
- Have sepsis as defined by an infection together with two or more SIRS criteria
- Evidence of acute organ dysfunction and/or Shock.
You may not qualify if:
- Patients less than 18 years of age
- Patients in whom the sepsis has been present from before the beginning of the study period
- Any patients previously included in the study during the same study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
All centres willing to contribute are welcome.
Brussels, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew RHODES, MD, PhD
European Society of Intensive Care Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2013
First Posted
September 17, 2013
Study Start
November 1, 2013
Primary Completion
November 1, 2013
Study Completion
January 1, 2014
Last Updated
August 20, 2014
Record last verified: 2014-08